Bridgerton‘s Jonathan Bailey is set to star in the Showtime limited series Fellow Travelers, opposite Matt Bomer and Allison Williams, according to Deadline. The political thriller follows “the volatile romance of two very different men who meet in the shadow of McCarthy-era Washington.” Bomer will play handsome, charismatic Hawkins Fuller, who avoids emotional entanglements, until he meets Bailey’s Tim Laughlin, a young Fordham University graduate, earnest about his political and religious convictions and filled with optimism about the post-WWII future. Meanwhile, Bailey will return to Bridgerton for season three…
TBS has canceled Nasim Pedrad‘s coming-of-age sitcom Chad ahead of its season-two premiere on Monday, according to Entertainment Weekly. The series follows a 14-year-old pubescent boy — played by Pedrad — navigating his first year of high school on a mission to become popular. The cable network hopes to find another home for the series created and executive-produced by the Saturday Night Live alum…
Midway through its freshman season, Apple TV+ has handed a season-two renewal to Loot, the comedy series starring Saturday Night Live alum Maya Rudolph. Loot centers on Rudolph’s billionaire Molly Novack, whose life spirals downward after her husband of 20 years betrays her. With the help of her devoted assistant Nicholas, played by Kim Booster, and Michaela Jaé Rodriguez‘s Sofia Salinas, who runs Novack’s charity foundation, Molly embarks on a journey of self-discovery. Nat Faxon, Ron Funches and Stephanie Styles also star…
(NEW YORK) — Since the U.S. Supreme Court’s overturning of Roe v. Wade, ending nearly five decades of a precedent that protected the constitutional right to an abortion, there has been a lot of public debate and confusion over what constitutes an abortion and what is considered legal.
Emergency contraceptive medications such as Plan B, also known as the morning-after pill, taken to prevent pregnancy after unprotected intercourse, have also been falsely interpreted by some as a form of abortion.
With no exact consensus, some states have defined “life” as beginning at conception or fertilization — the moment egg meets sperm. Meanwhile, the American College of Obstetricians and Gynecologists (ACOG) — the nation’s leading physician group for OB-GYNs — says complex medical concepts are being “misused” by state legislators.
“Conception and pregnancy are not the same thing,” said Dr. Elizabeth Schmidt, assistant professor of obstetrics and gynecology and director of family planning at North Shore University Hospital in New York. “Conception is not a medically recognized term.”
But doctors say the debate about when life begins shouldn’t have any bearing on Plan B, which works to stop pregnancy even earlier in the process — before fertilization, or conception.
What is Plan B?
Plan B is a progesterone hormone, which prevents ovulation or the release of an egg when taken at the appropriate time. This effectively prevents fertilization or the meeting of the sperm and egg for pregnancy. If taken after ovulation has already occurred, Plan B has no effect and there is no evidence that it harms an already established pregnancy, according to ACOG.
“Pregnant people make progesterone, and Plan B is a type of progesterone, so it makes sense that it would have no effect on a developing embryo,” Schmidt told ABC News.
Why is it confused with abortion?
Some of the confusion may stem from the Food and Drug Administration’s own website, which explains that Plan B “may prevent a fertilized egg from attaching to the womb (implantation).” The problem, experts say, is that this description is not accurate.
When the FDA first approved emergency contraception back in the late 1990s, it wasn’t totally clear how the pills prevented pregnancy, said Susan F. Wood, Ph.D., George Washington University professor and former director of the FDA’s Office of Women’s Health.
Now, she said, “new evidence [that has] been around for about 10 years now has shown that actually, Plan B works, probably essentially only through that first mechanism — blocking ovulation.”
Still, the FDA’s statement has been interpreted by some to imply abortion, resulting in objections to Plan B.
How does Plan B work?
“When used as emergency contraception, Plan B only affects ovulation,” Schmidt said. “Studies have failed to show any effect from levonorgestrel on the uterine lining when used as a one-time dose in emergency contraception.”
In a 2001 study published in Contraception, scientists looked at 45 women who were treated with short-term levonorgestrel administration — the same hormone found in Plan B — and observed no impairment in the lining of the uterus whether levonorgestrel was administered around or after ovulation. Previous studies on monkeys and rats have also failed to show a significant effect of the levonorgestrel hormone on uterine lining to prevent the implantation of a fertilized egg.
Taken collectively, this evidence suggests Plan B works primarily on the first step in the process — preventing the body from releasing an egg in the first place, or ovulating.
If the body has already released an egg prior to taking Plan B, the drug does not stop an egg from meeting sperm, and it does nothing to prevent a fertilized egg from implanting in the uterus.
Wood said given the current legal environment, the FDA should consider updating the language on its website “to pull Plan B out of the line of fire” from anti-abortion groups.
When reached for comment by ABC News, an FDA spokesperson did not comment directly on the language on its website but emphasized that “emergency contraception is used to reduce the chance of pregnancy after unprotected sex.”
“Plan B is an extremely safe medication and there are no medical contraindications to its use. It is safer than Tylenol — which is sold over the counter without restriction,” Schmidt said.
Although contraception currently remains legal throughout the U.S., the growing abortion restrictions in the country are now bringing some forms of contraception into question.
In his concurring opinion on the overturning of Roe v. Wade, Supreme Court Justice Clarence Thomas wrote that in the future, the court should reconsider other “demonstrably erroneous” precedents, including the 1965 ruling in Griswold v. Connecticut, which protects the right of married couples to buy and use contraception without government restriction.
“Limiting access to any medical care can have disastrous effects on communities,” Schmidt said. “It has been shown that states with restricted access to abortion also have higher rates of maternal and infant mortality. The situation is going to get even worse by prohibiting access to emergency contraception and abortion, which will disproportionately affect the most vulnerable and disadvantaged.”
Dr. Esra Demirel is a fellow in Minimally Invasive Gynecologic Surgery at NYU Langone Health and is a contributor to the ABC News Medical Unit.
ABC News’ Anne Flaherty contributed to this report.
(NEW YORK) — A French-based pharmaceutical company announced Monday that it has asked the Food and Drug Administration to sell over-the-counter birth control pills in the U.S., making it the first business to file an official application.
Perrigo’s HRA Pharma said it hopes that regulatory approval comes early next year.
“This historic application marks a groundbreaking moment in contraceptive access and reproductive equity,” Frédérique Welgryn, chief strategic operations and innovation officer at HRA Pharma, said in a statement.
“More than 60 years ago, prescription birth control pills in the U.S. empowered women to plan if and when they want to get pregnant,” Welgryn said. “Moving a safe and effective prescription birth control pill to OTC will help even more women and people access contraception without facing unnecessary barriers.”
Currently, hormone-based birth control pills require a doctor’s prescription because of health concerns such as blood clotting in some women. But most doctors say the risk is minimal for the vast majority of the population and note that pregnancy can carry its own significant health risks.
Reproductive rights advocates say an over-the-counter pill would make it easier for women without access to health care to obtain contraceptives.
“In the wake of the overturn of Roe v. Wade, we must pull out all the stops to make it easier and more affordable for everyone to secure contraception and take bold steps to protect women by ensuring that health — not politics — guides medical decisions,” said Michigan Gov. Gretchen Whitmer, a Democrat.
The FDA did not immediately respond to ABC News’ request for comment.
According to the Centers for Disease Control and Prevention, 65.3% of women aged 15 to 49 use contraception, with 14% taking pills.
The move comes weeks after the U.S. Supreme Court overturned Roe v. Wade, which granted people a constitutional right to an abortion for nearly 50 years.
Senate Republican Leader Mitch McConnell had said it was a relief, calling Roe v. Wade “one of the most egregious legal and moral mistakes of the 20th century.”
The fallout from Roe’s reversal has many people worried that the Supreme Court will overturn other constitutionally protected rights.
In his concurrent opinion, Supreme Court Justice Clarence Thomas called for the court to reconsider other cases, including Griswold v. Connecticut, which gave married couples the right to use contraception.
He also asked the court to reconsider Lawrence v. Texas, which protects the right to same-sex romantic relationships; and Obergefell v. Hodges, which establishes the right to same-sex marriage.
“In future cases, we should reconsider all of this Court’s substantive due process precedents, including Griswold, Lawrence, and Obergefell. Because any substantive due process decision is “demonstrably erroneous,” we have a duty to “correct the error” established in those precedents,” Thomas wrote.
ABC News’ Kiara Alfonseca contributed to this report.
Tuesday morning, a collection of stars will get the early morning wake-up call for which they might have been dreaming the night before: Finding out they’re nominated for an Emmy.
Stand-up comedian and Curb Your Enthusiasm star JB Smoove will read the nominees live Tuesday morning, along with Brooklyn Nine-Nine‘s Melissa Fumero, ahead of September’s 74th Annual Emmy Awards telecast.
This year, prognosticators seem to agree Hulu’s Only Murders in the Building is ripe for some trophy love in the Outstanding Comedy category, especially considering other likely nominees like FX’s Atlanta, Hacks on HBO, Amazon’s The Marvelous Mrs. Maisel, and Ted Lasso have already won. ABC’s new school comedy Abbott Elementary could snag its first noms.
Then again, there are always the surprise nominations, particularly in the broadly-defined comedy category — like Amazon Studios’ The Boys was last year.
In the drama category, it would be a lay-up for Netflix’s biggest-ever hit Squid Game to get some attention. The show certainly has its fans in the entertainment industry, with Steven Spielberg among those touting creator Hwang Dong-hyuk‘s twisted Korean survival show.
Alongside that import could be previous winners like HBO’s Euphoria and Succession, NBC’s just-wrapped, Emmy-winning drama This Is Us, and Netflix’s hailed Ozark. Stranger Things could also be in the running outside the usual technical categories.
With Emmy magnet The Crown out of contention this year, it opens up more possibilities, including more focus on previous nominees like Better Call Saul, as well as recognition for quirky upstarts that found an audience, including Showtime’s Yellowjackets, as well as another smash, Paramount Network’s Yellowstone.
As they say in TV, stay tuned.
The 74th Emmy Awards will air on NBC Monday, September 22 and also stream on Peacock.
(NEW YORK) — Health officials are once again raising the alarm about the threat of a resurgence of COVID-19 infections across the country, as concerns grow about the new omicron subvariant, BA.5, which is now the dominant viral strain in the U.S.
The BA.5 variant, first detected in South Africa earlier this year, is currently estimated to account for more than half — 53.6% — of all new COVID-19 cases in the states, according to the Centers for Disease Control and Prevention.
BA.5 appears to have a growth advantage over the original omicron variant, according to the World Health Organization, and scientists are closely monitoring the increase in reported cases observed in many countries across the globe.
At this time, BA.5 does not appear to have increased in severity, but officials have previously stressed that research on the new subvariant is still in its “early days,” and much remains to be learned about it.
As BA.5 spreads, a growing proportion of U.S. counties are seeing increases in infections and related hospital admissions.
Nearly three-quarters of the U.S. population is now living in a county with a high or medium community risk level for COVID-19, as defined by the CDC, federal data shows. About one-third of those people — 31.9%– are living in a high-risk community, while 41.6% are living in a medium-risk county.
A high community level suggests there is a “high potential for health care system strain” and a “high level of severe disease,” and the CDC recommends that people wear a mask in public indoor settings, including schools. A medium-risk level suggests there is “some impact on [the] health care system,” and “more people with severe disease.” Under the CDC’s official guidance, individuals considered at “increased risk” are advised to speak with their health care provider about whether to wear a mask.
Counties on both coasts — most notably in California, Montana, New Mexico and Oregon — are moving up and entering the high-risk level. In Florida, nearly every county is currently considered high risk. Puerto Rico and California currently lead the nation in new cases per capita, followed by New York City, where officials are once again urging residents to wear high-quality masks in indoor public settings and around crowds outside, amid a renewed surge of infections in the city.
“We’re currently seeing high levels of COVID-19 in NYC. To help slow the spread, all New Yorkers should wear a high-quality mask, such as an N95, KN95 or KF94 in all public indoor settings and around crowds outside,” the New York City Health Department wrote in a tweet on Friday, after the city moved back into the high-risk level.
The average number of new cases across New York City is up by 25% in the last two weeks, according to federal data. City data also shows that an average of 15% of reported tests are now coming back positive, marking the highest seven-day positivity rate in months.
Nationally, the country is currently reporting an average of more than 100,000 new cases each day. However, health officials say that the total is likely significantly undercounted.
As previously reported, dozens of states have moved to shutter public testing sites, with more at-home COVID-19 tests now available in pharmacies and through the federal testing program. Most Americans are not reporting their results to officials, and, thus, experts said infection totals are likely significantly undercounted.
Last week, White House COVID Response Coordinator Dr. Ashish Jha told NBC News that hundreds of thousands of COVID-19 infections are likely going undercounted.
“There’s no question in my mind we are missing the vast majority of infections right now,” Jha said. “The truth is there are probably several hundred thousand — 400,000; 500,000 infections a day happening across the country.”
The concerns over BA.5 come amid the nation’s continued push to get people vaccinated. Although the U.S. is set to roll out new bivalent vaccines in the fall, which will address omicron, millions of eligible Americans are still without their additional shots.
To date, less than half of eligible Americans — 49.5% or 108.6 million people — have received their first booster. Similarly, less than one-third — 29.5% or 42.2 million — of eligible Americans over the age of 50 have received their second booster.
Overall hospitalization numbers and death rates have yet to see a significant resurgence, though experts say metrics may also be undercounted, due to a lack of reporting from states.
As of July 5, about 34,000 patients are currently receiving care in U.S. hospitals across the country. This still marks one of the highest numbers of patients hospitalized with the virus since March.
On average, more than 5,200 virus-positive Americans are entering the hospital each day — the highest number of daily admissions since February. Hospital admissions in the Southwest and the South are up by more than 10%, respectively, in the past week.
The average number of daily COVID-19-related deaths remains just below 300 reported each day. Totals are still much lower than during prior COVID-19 surges.
However, thousands of Americans are still losing their lives every week. Over the last seven days, the U.S. has reported nearly 2,000 deaths.
(WASHINGTON) — The White House on Monday cited some of its past successes as it played down a new New York Times/Siena College poll showing President Joe Biden’s approval rating almost scraping 30% — and Democrats pushing, at this point some two years out, for a different candidate in the 2024 race.
White House press secretary Karine Jean-Pierre told reporters that the administration remains focused on the issues at hand despite the latest survey, which showed only 33% of respondents approve of the job Biden is doing and 64% of Democratic voters saying they want someone else to be the party nominee in the next presidential election.
“Not to get into politics from here or get into any political analysis, [but] this is not something — there’s going to be many polls. They’re going to go up, they’re going to go down, this is not the thing that we are solely focused on,” Jean-Pierre said at Monday’s press briefing before noting Biden’s celebration of a bipartisan anti-gun violence package earlier in the day.
“We are focused on things like today, signing this bipartisan gun reform legislation, which will, again, save lives. Do we have more work to do? Absolutely. I was talking about inflation and how … that is a priority for this president, how we have seen gas prices go down by close to 30 cents per gallon the past 25-plus days,” Jean-Pierre said. “That is something that the president is going to continue to work on because we still need to give Americans relief.”
The press secretary rattled off other priorities, like maintaining job growth and pushing a bill to increase competitiveness with China, insisting that Biden will remain locked on those issues in spite of any poor polling — which, administration supporters were also quick to note, did show him winning a hypothetical rematch with Donald Trump.
“We’re not gonna pay attention to polls, it’s not what we’re going to do here. But [what] we’re going to focus on is delivering for the American people,” Jean-Pierre said.
“There is so much work to be done that the president is going to focus on and deliver as well,” she said.
Still, Jean-Pierre recognized the widespread dissatisfaction exemplified in the poll, with more than 75% of respondents saying America was headed in the wrong direction — though, given the country’s polarization, it is surely for varying and contradictory reasons.
“We understand what the American people are feeling. We understand that. We understand that inflation is hurting families when they are around the kitchen table. When they are trying to figure out, you know, how they are going to deal with gas prices at the pump, how they’re going to deal with food prices as well,” Jean-Pierre said.
The latest poll comes amid a spate of poor surveys for Biden, whose approval rating has sunk under the pressure of stubbornly high inflation, the expensive cost of gasoline and more even as the administration has touted what it says is a little-credited economic recovery, with robust employment, and other legislative breakthroughs including on guns and infrastructure.
The Times/Sienna polling — as well as the fact that Biden, at 79 years old, is already the country’s oldest-ever president — has refueled concerns from some Democrats over his viability to win reelection in two years.
But as the Times poll also showed, Biden narrowly comes out on top — 44 to 41 — in the expected matchup with former President Trump.
In a further sign that defeating Trump would be a top priority for Democratic voters, over any particular policy, 92% of Democrats in the poll said they would stick with Biden in such a contest.
(WASHINGTON) — A federal judge on Monday rejected a series of explanations by former Trump White House adviser Steve Bannon as to why he failed to comply with a subpoena issued by the House committee investigating the Jan. 6 attack on the U.S. Capitol, reinforcing the legal challenges that Bannon is currently facing.
Bannon was charged last year with two counts of criminal contempt of Congress after defying the panel’s subpoena, and Judge Carl Nichols said in Monday’s pretrial hearing that he would not delay Bannon’s trial, which is set to begin next Monday.
“I see no reason for extending this case any further,” said Nichols.
On the eve of the Monday’s pretrial hearing, Bannon — who for months had refused to comply with the subpoena by claiming absolute “immunity” from congressional subpoenas due to his previous role within the Trump White House — suddenly offered to testify before the Jan. 6 committee, a move that prosecutors in a court filing have described as a “last-ditch effort to avoid accountability.”
The hearing also followed a revelation by the Justice Department that federal investigators interviewed former Trump attorney Justin Clark two weeks ago in connection with Bannon’s case.
Among the overarching arguments that Nichols rejected was Bannon’s claim that he defied the subpoena because former President Donald Trump had asserted executive privilege over his testimony, an argument Bannon’s lawyers said was based on DOJ Office of Legal Counsel opinions. Judge Nichols noted that the opinions referenced do not apply in Bannon’s case because they do not pertain to someone in Bannon’s position as a former White House official to a former president. Bannon has not worked in the White House since 2017.
In a blow to Bannon’s defense, Nichols ruled that Bannon cannot present to the jury evidence that he relied on those internal Justice Department opinions — or on his counsel’s advice — as the reason for declining to appear, saying those factors don’t serve as appropriate reasons for Bannon’s decision not to comply.
Nichols also rejected Bannon’s “entrapped by estoppel” defense, which argued that he was “tricked” into believing he was entitled to ignore the subpoenas due to the DOJ opinions, on the grounds that the DOJ opinions do not specifically deal with Bannon’s situation.
In addition, the judge ruled that Bannon cannot present a “public authority” defense, because Trump was no longer a federal official by the time Bannon was subpoenaed.
“The former president, in his civilian capacity, is by definition not a federal official” and “never instructed Mr. Bannon not to show up altogether,” the judge ruled.
The judge also rejected Bannon’s defense that prosecutors would need to show that he knew his conduct was unlawful, saying that prosecutors only need to prove that Bannon acted “deliberately” and “intentionally” to defy the Jan. 6 panel.
Bannon’s attorney, David Schoen, questioned the judge’s rulings.
“What’s the point in going to trial here if there are no defenses?” Schoen said before the judge.
In a win for Bannon, Nichols said he will allow his defense team to present evidence about prior subpoenas regarding whether Bannon thought the date was flexible, allowing Bannon to argue that he misunderstood the subpoena’s due date or believed in good faith that the deadline could be extended.
The judge also ruled that he would allow Bannon’s defense team to cross examine certain witnesses to introduce evidence of “political bias.”
However, Nichols granted a motion from the House committee to quash 16 trial subpoenas that Bannon’s attorneys had sent to 12 members of Congress and four staffers, and he rejected the defense’s assertion that the Jan 6. Committee is not “properly composed,” saying “the entire House has on multiple occasions ratified that the committee is validly constituted.”
Following the hearing, Schoen suggested to reporters that he might appeal Nichols’ rulings.
“That’s why they have a court of appeals,” said Schoen when asked how he felt about the judge’s decisions.
In their filing overnight, prosecutors said the timing of Bannon’s sudden offer to testify suggests that “the only thing that has really changed since he refused to comply with the subpoena in October 2021 is that he is finally about to face the consequences of his decision to default.”
(NEW YORK) — A new report found a “statistically significant” excess of cancer cases among people of all ages living within a Long Island school district compared to similar areas of the state.
The report, from the New York State Department of Health, looked at cancer cases over 20 years within the Northport-East Northport School District in Suffolk County — about 45 miles from Manhattan.
Researchers say the investigation is still in its early stages and does not mean people living in these areas need to immediately get cancer screenings.
Looking at data from the New York State Cancer Registry, researchers conducted an analysis comparing the number of cancer cases found with the number of cases that would be expected to be found.
Within the entire district, the report identified 4,593 total cancer cases, a 3% excess than the 4,454 cases that would be expected. Specifically, the DOH found “significant excesses in numbers of cases of pancreatic cancer, malignant melanoma of the skin, uterine (corpus) cancer and prostate cancer.”
“Cancer clusters are certainly an area of intrigue because we want to be able to identify if there are certain hotspots for cancer,” Dr. Arif Kamal, chief patient officer of the American Cancer Society, told ABC News.
Kamal said the interesting aspect of this case is that “if you look at the particular cancers that are represented, there’s not a single factor that tied them all together,” indicating a “mixture of explanations.”
When looking specifically at the Northport Middle School District, researchers detected 2,655 total cases of cancer, a 7% excess than the 2,486 cases expected, with “significantly greater than expected numbers of cases of malignant melanoma and prostate cancer.” However, the report found that the East Northport Middle School area did not have a significantly different total number of cancer cases from the number expected.
The department said it initiated the investigation in 2019 after members of the community shared a concerning number of graduates in the Northport High School class of 2016 who had been diagnosed with leukemia. Officials found around five graduates were diagnosed with leukemia, which was “statistically unusual” and much higher than the two cases that would be expected.
The DOH said it does not believe the study should cause alarm and that the higher number of leukemia cases may be “due to chance.”
Kamal said the higher number of leukemia cases is “concerning, but it’s a little early to make conclusions about what it means.”
“Leukemia can be a canary in a coal mine because a lot of environmental exposures can lead to it, but it needs to be followed over time to really understand,” he said. “If after five to 10 years those rates increase, you really should be worried.”
The district has battled concerns about toxic chemicals on school grounds for years and, in September 2020, parents filed a class action lawsuit against the district citing negligence. In the lawsuit, they allege the district “knew or should have known about the presence” of the presence of “contaminants” on its campus including benzene, mold, chlordane, mercury, lead, carbon monoxide and petroleum products.
Tara Mackey, the lead plaintiff, told ABC News her daughter attended Northport Middle School from 2015 to 2018. The lawsuit claims that in 2017, the district notified parents about a chemical spill beneath classrooms in the school’s K-wing.
“My daughter was in seventh grade when they told us about the chemicals they found under the K-wing,” she said. “She was suffering from migraines. Some days it would be so bad she would come home, and she would vomit.”
Mackey said she took her daughter to the pediatrician to be tested, and when the pediatrician called her back, she was shocked by the blood test results.
“My seventh-grade daughter had carbon monoxide levels equal to a two-, three-pack-a-day smoker,” Mackey said.
Mackey’s daughter just graduated high school in North Carolina, and although she currently does not suffer from migraines, she did develop asthma while attending Northport Middle School.
When the district was contacted by ABC News, Syntax Communication Group — which represents the district — replied, “The Northport-East Northport School District does not comment on active litigation and will not be providing comment.”
(WASHINGTON) — The Justice Department has opened a probe against the PGA Tour to see if the tour violated any antitrust laws in relation to their face-off with LIV Golf — a Saudi-backed golf league — a PGA Tour spokesperson confirmed to ABC News.
The PGA Tour says the probe was not unexpected, and they are confident they’ll be vindicated. They didn’t say what specifically the Justice Department was looking into.
The Wall Street Journal was first to report the probe, and the Justice Department is not commenting on the probe.
Financed by the government of Saudi Arabia’s Public Investment Fund, the LIV Golf league burst onto the scene last year as a potential rival to the PGA Tour, reportedly offering large sums of money to some of the PGA Tour’s top players while promising to shake up the world of golf with a new format and larger prize money for tournament winners.
The commissioner of the LIV Golf league is two-time major champion Greg Norman. The retired golfer has been outspoken about the PGA Tour format.
The PGA Tour has banned and fined golfers like Dustin Johnson, Phil Mickelson and Bryson DeChambeau who joined the upstart golf league and are some of the biggest and most winningest players in the sport.
The probe is just the latest in the back-and-forth between the league backed by the Saudi government and the PGA Tour.
“We welcome good, healthy competition,” PGA Tour Commissioner Jay Monahan told reporters in late June when asked about the league. “The LIV Saudi Golf League is not that. It’s an irrational threat, one not concerned with the return on investment or true growth of the game.”
In a February letter to Monahan, Norman, who has won two major championships, chided the commissioner saying PGA Tour lawyers must be “holding their breathe.”
“But when you try to bluff and intimidate players by bullying and threatening them, you are guilty of going too far, being unfair, and you are likely in violation of the law,” Norman wrote.
LIV Golf has not responded to requests for comment by ABC News.
This week, the Open Championship, one of the four major golf championships, gets underway at St. Andrew’s in Scotland.
In 1994, the Federal Trade Commission looked into “unfair methods of competition,” that the PGA Tour was allegedly carrying out, but they were found to have not violated any federal laws.
ABC News’ Alexander Mallin contributed to this report.
(WASHINGTON) — The first full-color image from NASA’s James Webb Space Telescope has been released.
The images, the full set of which will be released Tuesday morning, will be the deepest and highest resolution ever taken of the universe, according to NASA.
The telescope will help scientists study the formation of the universe’s earliest galaxies, how they compare to today’s galaxies, how our solar system developed and if there is life on other planets.
Here’s how the news is developing. All times Eastern:
President Joe Biden unveiled the first full-color image taken by the James Webb Space Telescope.
The image, revealed during a press event held at the White House Monday and also attended by Vice President Kamala Harris, shows multiple galaxies.
It is the highest-resolution image of the universe ever captured, officials said.
“Today is a historic day,” said Biden. “It’s a new window into the history of our universe and today we’re going to get a first glimpse of the light to shine through that window.”
NASA Administrator Bill Nelson said the light seen on the image has been traveling for over 13 billion years.
Jul 11, 4:46 pm
NASA says all of the telescope’s instruments are ‘ready’
NASA announced Monday all four of the James Webb Space Telescope’s scientific instruments are ready to start being used.
The space agency said there are 17 modes, or ways, to operate the instruments. All have been examined and are “ready to begin full scientific operations.”
The last step was was checking the the telescope’s NIRCam, which block starlight so scientists can detect other nearby structures, such as exoplanets.
Jul 11, 4:00 pm
Test image from telescope offers preview
A test image taken by the James Webb Telescope offers a preview of what’s to come ahead of the release of the first full-color images.
NASA shared the photo last week taken by one of the telescope’s instruments, the Fine Guidance Sensor, or FGS, to demonstrate how strong, clear and sharp Webb’s images will be.
According to the space agency, the “false-color mosaic” is made up of 72 exposures taken over a 32-hour period.
NASA noted that the primary focus of the FGS is not even to capture images but to make sure the telescope is pointing precisely at its target.
Jul 11, 3:30 pm
What to know about the Webb telescope
The James Webb Space Telescope was jointly developed by NASA, the European Space Agency and the Canadian Space Agency.
Development began in 1996 but ran into several delays before it was completed in 2016 at a final cost of $10 billion.
The telescope was launched on Christmas Day and is orbiting 1 million miles from Earth.
It used infrared radiation to detect objects that are invisible to the human eye.
The four goals of the telescope are to study how the first stars and galaxies formed right after the Big Bang, comparing the galaxies from the past to those of today, how planetary systems formed and if there is any sign of life on other planets.
